CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-15 | Barrett Scott CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +110,000 | 110,000 | ||
| 2022-03-22 | Barrett Scott CHIEF MEDICAL OFFICER | Purchase | +900 | $7.49 | $7K | 7,563 |
| 2022-02-10 | Barrett Scott CHIEF MEDICAL OFFICER | Grant or award · Stock Option | +71,850 | 71,850 | ||
| 2021-08-03 | Barrett Scott Chief Medical Officer | Conversion | +5,996 | 5,996 | ||
| 2021-08-03 | Barrett Scott Chief Medical Officer | Purchase | +667 | $15.00 | $10K | 6,663 |
| 2021-08-03 | Barrett Scott Chief Medical Officer | Conversion · Series A Preferred Stock | −3,273 | 0 | ||
| 2021-08-03 | Barrett Scott Chief Medical Officer | Conversion · Series B Preferred Stock | −2,723 | 0 |
Page 1 of 1 · 7 trades